⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
KURA News
Kura Oncology, Inc.
Form 8-K
sec.gov
KURA
Kura Oncology Launches Caspian Therapeutics with $50 Million Financing to Advance Menin Inhibition as a Potential Disease-Modifying Approach for Diabetes
globenewswire.com
KURA
Form 8-K
sec.gov
KURA
Kura Oncology Appoints Jennifer Fulk as Chief Financial Officer
globenewswire.com
KURA
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
KURA
Kura Oncology to Participate in Three Investor Conferences in September
globenewswire.com
KURA
Form 8-K
sec.gov
KURA
Kura Oncology Reports Second Quarter 2026 Financial Results
globenewswire.com
KURA
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
KURA
Kura Oncology to Report Second Quarter Financial Results
globenewswire.com
KURA